gwph好像有机构买入# Stock
T*M
1 楼
Morgan Stanley initiated coverage on GW Pharma (NASDAQ: GWPH) with an
Overweight rating and a price target of $103.00. Analyst David Friedman
thinks the company's novel cannabis platform and epilepsy drug will drive
value.
Overweight rating and a price target of $103.00. Analyst David Friedman
thinks the company's novel cannabis platform and epilepsy drug will drive
value.